- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cancer & Blood Specialists of Louisville Adds New PET/CT Scanner to Improve Cancer Treatment
Patients to benefit from new technology that enables physicians to more accurately diagnose and locate cancers.
FORT MYERS, FLA., August 23, 2019 — Cancer & Blood Specialists of Louisville, a practice in the American Oncology Network, LLC (AON), is now offering patients a powerful new diagnostic imaging system known as positron emission tomography/computed tomography (PET/CT). This technology combines the power of hybrid imaging in one exam to enable physicians to more accurately detect and pinpoint disease—helping to improve patient outcomes.
PET/CT scans are noninvasive and painless and take about 30 minutes to perform. In addition to providing state-of-the-art imaging data, PET/CT scans offer added comfort and convenience by reducing the number of diagnostic sessions a patient must undergo.
“PET/CT scans allow for the most accurate detection of the location, size and shape of tumors and lesions," explained Jeff Esham, MBA, RT(R)(T), AON vice president of radiation oncology and radiology. "With this technology, our physicians are able to see changes within the cancer in ways that had never before been possible.”
Linvoseltamab Added as Preferred Agent in Newest MM Practice Guidelines
July 31st 2025On July 2, linvoseltamab-gcpt (Lynozyfic; Regeneron) received an accelerated approval from the FDA in relapsed/refractory multiple myeloma (MM), and the most recent update to the National Comprehensive Cancer Network guidelines for MM has added the BCMA-targeted bispecific antibody as a preferred treatment option.
Read More
